All Posts

myocardial-infarction-market-treatment-growth-size-therapies-forecast-key-companies
Increasing Incidence, Influx of Companies add to the Market Revenue in the Myocardial Infarction Market Space

Myocardial infarction is an irreversible death of heart muscles. It is pathologically referred to as myocardial cell death due to a prolonged lack of oxygen supply (ischemia). The condition is accompanied by chest pain that may appear as a sensation of tightness or pressure initially attributable to diminished cell...

Find More

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies
Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This impairment prevents critical muscle contractions from occurring, resulting in muscle weakness. This disease is associated with antibodies directed a...

Find More

medtech-happenings-for-neurolief-paige-bionaut-retina-medtronic
RETINA-AI Health declares positive results; Medtronic’s Hugo robotic-assisted surgery system; Boston Scientific acquires Devoro Medical; Paige obtains first-ever FDA approval

RETINA-AI Health, Inc. declares positive pivotal study results for the RETINA-AI Galaxy™ autonomous Diabetic Retinopathy screening device On September 20, 2021, RETINA-AI Health, Inc. announced optimistic results from the pivotal study of the RETINA-AI Galaxy™, a multi-device compatible autonomous ...

Find More

Probiotics Market
Analyzing the Emerging Demand for the Probiotics

Probiotics are a type of beneficial or live bacteria that provides various valuable benefits such as boosting the immune system and maintaining digestive health. Due to their beneficial properties, the demand is growing at a significant rate. Probiotics are available as dietary supplements. In the food supplemen...

Find More

pharma-biotech-news-updates-for-innovent-biohaven-delix-intracellular-therapies
UNION Therapeutics-Innovent’s collaboration; Delix Therapeutics bags $ 70 M; Biohaven’s Verdiperstat clinical trial result; Intra-Cellular’s CAPLYTA Phase III study

Innovent, UNION Therapeutics Set to Advance Dermatology Market in China  Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and commercialize Orismilast, a next-generation PDE4 inhibitor for inflammatory dermatology conditions in China. Orismilast ...

Find More

west-syndrome-market-epidemiology-therapies-treatment-therapeutics-cagr-trends-size-share-growth
Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epileptic Encephalopathy that displays an umbrella of symptoms such as seizures known as epileptic (infantile) spasms, gross EEG abnormalities of hypsarrhythmia and intellectual disability.  There are many different causes of epi...

Find More

IgA Nephopathy Market | IgAN Market
Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the IgA Nephropathy Market Share Growth

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. Factors such as population aging, lifestyle-modifiable risk factors, a decline in early-life infectious diseases, sedentary lifestyle, unhealthy food habits have resulted in the emergence of chronic diseases as a major global hea...

Find More

pharma-biotech-news-updates-for-novartis-boston-scientific-boehringer-ingelheim
Boston Scientific pays $336M; Boehringer Ingelheim acquires Abexxa Biologics; Oncology, RNA biotech 858 Therapeutics inks $60M Series A; Novartis acquires Arctos Medical

Boston Scientific pays USD 336 Million to acquire blood clot medical device firm Boston Scientific Corp. is shelling out as much as USD 336 million to take over the rest of medical device firm Devoro Medical, which it has held a stake in since 2019. The payment comprises USD 269 million paid upfront for the 8...

Find More

Healthcare-Data-Breaches-Rising-Threat-Key-Companies-USA-and-Global-Cases-2020-2021
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeholders in a business environment such as companies, investors, and individuals deal with some or other kind of data in their day-to-day life. The data is key to the business prediction that helps to analyze consumer behavior. Comp...

Find More

pharma-biotech-news-updates-for-biogen-smartlabs-synlogic-partner-therapeutics
Biogen’s AMD Biosimilar Gets Approval; SmartLabs Series B Funding; BARDA, Partner Therapeutics in Sepsis Space; Synlogic to Explore Sepsis Market Domain

Win-win for Biogen as its Biosimilar Gets Approval for AMD  Samsung Bioepis and Biogen's biosimilar drug, Byooviz, received USFDA approval for the treatment of vision loss, Age-related macular degeneration and has become the first biosimilar to Lucentis in the AMD market. The Lucentis copycat had also manag...

Find More